Zobrazeno 1 - 10
of 1 309
pro vyhledávání: '"35"'
Autor:
Elizabeth Harvey-Jones, Angela Swampillai, Sameer Sengupta, Jasmine Timbres, Joanna Dodkins, Elinor J. Sawyer
Publikováno v:
Cancer Research. 81:PS7-83
Introduction Breast cancer is the most common malignancy affecting women under the age of 35 and young age at diagnosis is associated with a poor prognosis. Previous studies have shown that these patients have adverse tumour biology including high gr
Autor:
Yuan-Qi Zhang, Heng Huang, Anqin Zhang, Ying Lin, Yuhua Song, Zhen Shan, Hongmin Ma, Jianwen Li, Li Cai, Rui Zhuo, Zhiyong Wu, Xiangyang Song, Zhongyu Yuan, Lehong Zhang, Li Zhao, Nan Shao, Ailing Zhang, Jincai Zhong, Herui Yao, Weixiong Yang, Qian-Jun Chen, Kun Wang, Feihai Ling, Hui Liu
Publikováno v:
Cancer Research. 80:OT1-04
In SOFT study, subgroup analysis for hormone receptor-positive (HR+) breast cancer women younger than 35 years indicated better 5-year DFS in OFS+exemestane arm than OFS+tamoxifen. Since only about 11% of women included were younger than 35 years of
Autor:
N Rueth, Karen K. Swenson, M Knaack, Janet Krueger, Barbara Susnik, P Martone, SR Baldinger, Michaela Tsai, Erin Grimm, Tamera J. Lillemoe
Publikováno v:
Cancer Research. 79:P5-10
Background: While breast cancer is rare in women ≤ age 35, patients in this age group are more frequently diagnosed with aggressive cancer subtypes and pathologic germline mutations in cancer susceptibility genes than older patients. Higher recurre
Autor:
Jiyue Qin, John S. Condeelis, David Entenberg, Gina Kim, George S. Karagiannis, Xiaonan Xue, Joseph A. Sparano, Juan Lin, Jessica Pastoriza, Greg Yothers, Maja H. Oktay, Thomas B. Julian, Thomas E. Rohan, Stewart J. Anderson
Publikováno v:
Cancer Research. 81:35-35
Background: The purpose of this study was to evaluate whether there are differences in distant recurrence rates between Black and White women with localized breast cancer who participated in NCI-sponsored clinical trials, and thus had access to state
Autor:
Hua Ye, Yaru Duan, Shuiling Jin, Jianxiang Shi, Liping Dai, Chi Cui, Jianying Zhang, Peng Wang, Li Jitian
Publikováno v:
Cancer Research. 80:35-35
Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide with a high recurrence rate. Although immune-checkpoint treatment provides survival benefits for patients with HCC, the mortality of HCC is still high. Therefore,
Autor:
Zachary L. Skidmore, Jason Kunisaki, Ramaswamy Govindan, Ravindra Uppaluri, Malachi Griffith, Avinash Ramu, Kelsy C. Cotto, Yiing Lin, Obi L. Griffith, William C. Chapman, Yang-Yang Feng, Donald F. Conrad
Publikováno v:
Cancer Research. 80:2136-2136
The interpretation of variants in cancer is often focused on genomic alterations that have a known coding consequence. This analysis strategy excludes somatic mutations in non-coding regions of the genome and even exonic mutations may have unidentifi
Publikováno v:
Cancer Research. 73:P3-11
Background: Coping with cancer plays an important role in cancer survivorship. Especially in young patients, coping is significant because of anxieties regarding fertility, body image, heredity, symptoms of premature menopause, and psychosocial stres
Publikováno v:
Cancer Research. 78:35-35
There is strong evidence implicating exosomes, cell-derived nanoscale vesicles, and their protein cargo in facilitating dialogue between primary tumor cells and the premetastatic niche. Identified by our lab as one such protein, secreted nucleoside d
Autor:
Akemi Kataoka, Takayuki Kinoshita, Eriko Tokunaga, Norikazu Masuda, Tadahiko Shien, Shinji Ohno, Chikako Shimizu
Publikováno v:
Cancer Research. 71:P5-23
Background: The aim of this study is to clarify clinicopathological features of breast cancer in young women. Materials and methods: Clinicopathological characteristics were compared between young ( Comparison of clinicopathological factors between y
Autor:
Ho Ryun Won, Ji Min Lee, Bok-Soon Lee, Kyung Ah Kim, Haeng-Jun Kim, Chul-Ho Kim, Jae Won Chang, Bon Seok Koo, Hyun-Young Cha, Yeon Soo Kim, Dae Ho Kim
Publikováno v:
Cancer Research. 77:35-35
Background and purpose: It has been reported that the abnormal activation of receptor tyrosine kinases is associated with the development of many human carcinomas and the high activation of EGFR and Met mediates the tumorigenicity of laryngeal carcin